PE20001058A1 - Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial - Google Patents

Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial

Info

Publication number
PE20001058A1
PE20001058A1 PE1999000924A PE00092499A PE20001058A1 PE 20001058 A1 PE20001058 A1 PE 20001058A1 PE 1999000924 A PE1999000924 A PE 1999000924A PE 00092499 A PE00092499 A PE 00092499A PE 20001058 A1 PE20001058 A1 PE 20001058A1
Authority
PE
Peru
Prior art keywords
sodium
weight
gum
salt
refers
Prior art date
Application number
PE1999000924A
Other languages
English (en)
Inventor
Naresh Talwar
Himadri Sen
John N Staniforth
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/152,932 external-priority patent/US6261601B1/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of PE20001058A1 publication Critical patent/PE20001058A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA EN FORMA DE TABLETAS O CAPSULAS QUE COMPRENDE UN SISTEMA DE LIBERACION CONTROLADA DE DROGA QUE COMPRENDE a)DE 0,5 mg A 1200 mg DE UN COMPUESTO SIENDO DE PREFERENCIA CIPROFLOXACIN, ACICLOVIR, DILTIAZEN, RANITIDINA, CAPTOPRIL; b)DE 5% A 50% EN PESO DE UN GENERADOR DE GAS QUE COMPRENDE UNA SAL GENERADORA DE GAS Y UN ACIDO ORGANICO COMESTIBLE O SU SAL TAL COMO SULFITO DE SODIO, CARBONATO GLICINICO DE SODIO, BICARBONATO DE SODIO O POTASIO, BISULFITO DE SODIO, ENTRE OTROS; c)DE 5% A 50% EN PESO DE UN AGENTE DILATADOR O DESINTEGRADOR TAL COMO POLIVINILPIRROLIDONA DE ENLACE CRUZADO, CARBOXIMETILCELULOSA DE SODIO DE ENLACE CRUZADO, GLICOLATO DE ALMIDON DE SODIO, ENTRE OTROS; d)DE 0,1% A 30% EN PESO DE UN AGENTE VISCOSO SIENDO DE PREFERENCIA GOMA XANTICA, GOMA DE TRAGACANTO, GOMA DE KARAYA, GOMA DE GUAR Y ACACIA; e)DE 0.1% A 20% EN PESO DE UN POLIMERO GELIFICANTE CONTIENE UNA SAL SOLUBLE EN AGUA DE UN ACIDO POLIURONICO; e)0.5% A 20% EN PESO DE UN POLIMERO HIDROFILICO TAL COMO HIDROXIPROPILMETILCELULOSA, HIDROXIPROPILCELULOSA, ACIDO POLIACRILICO; TAMBIEN SE REFIERE A UNA TABLETA RECUBIERTA POR UNA CAPA DE UN POLIMERO SOLUBLE EN AGUA DE RAPIDA DISOLUCION
PE1999000924A 1998-09-14 1999-09-13 Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial PE20001058A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/152,932 US6261601B1 (en) 1997-09-19 1998-09-14 Orally administered controlled drug delivery system providing temporal and spatial control

Publications (1)

Publication Number Publication Date
PE20001058A1 true PE20001058A1 (es) 2000-10-05

Family

ID=22545063

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000924A PE20001058A1 (es) 1998-09-14 1999-09-13 Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial

Country Status (41)

Country Link
EP (2) EP1107741B1 (es)
JP (1) JP2002524494A (es)
CN (1) CN1186013C (es)
AP (1) AP1659A (es)
AR (1) AR022672A1 (es)
AT (1) ATE245414T1 (es)
AU (1) AU758324B2 (es)
BG (1) BG105339A (es)
BR (1) BR9913696A (es)
CA (1) CA2343760A1 (es)
CO (1) CO5130022A1 (es)
CU (1) CU23040A3 (es)
CZ (1) CZ2001901A3 (es)
DE (1) DE69909801T2 (es)
DK (1) DK1107741T3 (es)
EA (2) EA005767B1 (es)
EE (1) EE200100153A (es)
ES (1) ES2204098T3 (es)
GE (1) GEP20043216B (es)
HK (1) HK1037967A1 (es)
HR (1) HRP20010187B1 (es)
HU (1) HUP0103632A3 (es)
ID (1) ID29843A (es)
IL (1) IL141977A0 (es)
IS (1) IS5885A (es)
MX (1) MXPA01002634A (es)
MY (1) MY127952A (es)
NO (1) NO20011276L (es)
NZ (2) NZ523747A (es)
OA (1) OA11652A (es)
PE (1) PE20001058A1 (es)
PL (1) PL346798A1 (es)
PT (1) PT1107741E (es)
SI (1) SI1107741T1 (es)
SK (1) SK285478B6 (es)
SV (1) SV1999000152A (es)
TR (1) TR200100731T2 (es)
UA (1) UA73287C2 (es)
UY (1) UY25710A1 (es)
WO (1) WO2000015198A1 (es)
ZA (1) ZA995839B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU66202A (sh) * 2000-03-03 2005-09-19 Ranbaxy Laboratories Limited Sistem za kontrolisano otpuštanje ciprofloksacina nakon oralne primene u jednoj dnevnoj dozi
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
AU2006202275A1 (en) * 2000-06-26 2006-06-22 Bayer Healthcare Ag Sustained-release preparations of quinolone antibiotics and method for preparation thereof
JP3573287B2 (ja) 2000-08-08 2004-10-06 第一製薬株式会社 高吸収性固形製剤
IN192748B (es) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
WO2002045695A2 (en) 2000-12-05 2002-06-13 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
DE60237372D1 (de) * 2001-07-04 2010-09-30 Sun Pharma Advanced Res Co Ltd Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
CA2456976A1 (en) * 2001-08-16 2003-02-27 The State Of Oregon Acting By And Through The State Board Of Higher Educ Ation On Behalf Of Oregon State University Expandable gastric retention device
US6673369B2 (en) * 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
MXPA04004035A (es) * 2001-10-29 2004-10-29 Labopharm Inc Metodos y formas de dosis para mejorar la biodisponibilidad de agentes terapeuticos.
PL374280A1 (en) * 2001-11-13 2005-10-03 Yamanouchi Pharma Technologies, Inc. Soluble drug extended release system
PT1461017E (pt) 2001-11-19 2006-07-31 Lupin Ltd Composicao farmaceutica para a libertacao controlada de um antibiotico beta-lactamico
SK285383B6 (sk) * 2002-04-23 2006-12-07 Lupin Limited Kompozície matrice s modifikovaným uvoľňovaním, sdlhodobým účinkom
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
GB0501810D0 (en) * 2005-01-28 2005-03-09 Pharmakodex Ltd Chemotherapeutic formulations
AU2006263338A1 (en) * 2005-06-29 2007-01-04 Panacea Biotec Ltd. Pharmaceutical sustained release compositions and processes thereof
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
WO2010020098A1 (zh) 2008-08-18 2010-02-25 北京天衡药物研究院 胃滞留药物释出系统及其制备方法和用途
ZA200903854B (en) * 2008-06-19 2011-02-23 Univ Of The Witwatesrand Johannesburg A gastroretentive pharmaceutical dosage form
WO2011125075A2 (en) 2010-04-08 2011-10-13 Fdc Limited A novel gastroretentive delivery of macrolide
EP2415460A1 (de) * 2010-08-03 2012-02-08 ratiopharm GmbH Orale Darreichungsform von Pregabalin
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
WO2016081593A1 (en) * 2014-11-19 2016-05-26 Fmc Corporation Nanosuspension formulation
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
CN110996922A (zh) 2017-06-16 2020-04-10 卡希夫生物科学有限责任公司 用于持续药物递送的胃滞留剂型
EP4056172A1 (en) 2018-06-18 2022-09-14 Amneal Complex Products Research LLC Extended release compositions comprising pyridostigmine
US10744083B2 (en) 2018-06-27 2020-08-18 Kashiv Biosciences, Llc Self-regulating osmotic gastroretentive drug delivery systems
CN110448535A (zh) * 2019-09-04 2019-11-15 湖南宇山玉月农业科技有限公司 一种裂褶菌素胃漂浮片
CN111116794A (zh) * 2019-12-20 2020-05-08 蚌埠市鑫晟新材料科技有限公司 一种中性造纸用聚合材料的制备方法
CN115715765A (zh) * 2021-08-24 2023-02-28 江苏万邦生化医药集团有限责任公司 一种悬浮片剂
CN113768898A (zh) * 2021-09-14 2021-12-10 江苏万邦生化医药集团有限责任公司 悬浮的胶囊片

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798742B2 (ja) * 1986-07-03 1995-10-25 ゼリア新薬工業株式会社 徐放性製剤組成物
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤

Also Published As

Publication number Publication date
IL141977A0 (en) 2002-03-10
EA005767B1 (ru) 2005-06-30
AP2001002098A0 (en) 2001-03-31
IS5885A (is) 2001-03-12
DE69909801T2 (de) 2004-06-03
AU1779499A (en) 2000-04-03
NZ510487A (en) 2003-04-29
PT1107741E (pt) 2003-12-31
ATE245414T1 (de) 2003-08-15
CN1325299A (zh) 2001-12-05
HRP20010187A2 (en) 2002-04-30
TR200100731T2 (tr) 2001-06-21
EP1281397A1 (en) 2003-02-05
NO20011276L (no) 2001-05-10
MXPA01002634A (es) 2002-06-04
CO5130022A1 (es) 2002-02-27
PL346798A1 (en) 2002-02-25
BG105339A (en) 2001-11-30
CU23040A3 (es) 2005-04-14
MY127952A (en) 2007-01-31
HRP20010187B1 (en) 2004-04-30
CZ2001901A3 (cs) 2001-08-15
OA11652A (en) 2004-12-08
HK1037967A1 (en) 2002-03-01
AP1659A (en) 2006-09-06
JP2002524494A (ja) 2002-08-06
NZ523747A (en) 2004-04-30
DE69909801D1 (de) 2003-08-28
SI1107741T1 (en) 2004-02-29
EP1107741B1 (en) 2003-07-23
CA2343760A1 (en) 2000-03-23
NO20011276D0 (no) 2001-03-13
UA73287C2 (en) 2005-07-15
EE200100153A (et) 2002-06-17
WO2000015198A1 (en) 2000-03-23
SK285478B6 (sk) 2007-02-01
GEP20043216B (en) 2004-04-26
BR9913696A (pt) 2001-10-09
EP1107741A1 (en) 2001-06-20
DK1107741T3 (da) 2003-11-17
ZA995839B (en) 2000-03-28
CN1186013C (zh) 2005-01-26
HUP0103632A3 (en) 2005-06-28
ES2204098T3 (es) 2004-04-16
SV1999000152A (es) 2000-07-03
HUP0103632A2 (hu) 2002-02-28
AR022672A1 (es) 2002-09-04
EA200300847A1 (ru) 2003-12-25
ID29843A (id) 2001-10-18
EA200100346A1 (ru) 2001-10-22
EA004443B1 (ru) 2004-04-29
SK3472001A3 (en) 2001-10-08
AU758324B2 (en) 2003-03-20
UY25710A1 (es) 2000-03-31

Similar Documents

Publication Publication Date Title
PE20001058A1 (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial
ES2366721T3 (es) Empujador oros para dosificación controlada de agentes activos.
AR111572A2 (es) Formas farmacéuticas que contienen vardenafilo
ES2164424T3 (es) Preparacion farmaceutica solida.
PE71699A1 (es) Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
ES2331046T1 (es) Formulacion de liberacion controlada.
AR054782A2 (es) Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico
YU19501A (sh) Sistem za kontrolisano davanje lekova oralnim putem koji obezbeđuje vremensku i prostornu kontrolu
CO4960646A1 (es) Tabletas de metilcelulosa rapidamente desintegrables
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
WO1999045887A3 (en) Monolithic tablet for controlled drug release
ES2531215T3 (es) Sistemas de administración de fármacos que comprenden un agente de bloqueo selectivo de la serotonina 5-HT3 débilmente básico y ácidos orgánicos
PE20020307A1 (es) Forma de dosificacion de farmaco activada por hidrogel
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
AR065827A2 (es) Formas de dosificacion de liberacion sostenida de sertralina, sales de sertralina, composicion farmaceutica, procedimiento y preparacion y su uso en terapia
DE69620606T2 (de) Feste oral anzuwendende arzeneiform
KR20030013460A (ko) 치료제의 위 체류 및 방출 조절을 위한 급속 팽창성조성물과 이 조성물을 포함하는 제형
EP1595538A3 (en) Modified release tamsulosin tablets
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
AR054448A1 (es) Composiciones farmaceuticas que comprenden acido arsenioso, su sal de sodio y sus derivados destinada al tratamiento de cancer urogenital y de su metastasis
ATE211649T1 (de) Dosisform mit gesteuerter freigabe für kalium
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed